Delivery Order 36C25224D0011-36C25226N0134
- Not listed
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a delivery order valued at $128,732.91 for radiopharmaceuticals to support the Department of Veterans Affairs' Veterans Integrated Service Network 15 (VISN 15). The contract, issued on May 1, 2024, with an ultimate completion date of April 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will be conducted at the...
- Cardinal Health 414, LLC, a subsidiary of Dublin, Ohio-based Cardinal Health, Inc., was awarded a delivery order valued at $3.14M on October 1, 2025, to supply radiopharmaceuticals and related clinical products to Veterans Integrated Service Network 8 through the Department of Veterans Affairs. The contract employs firm fixed pricing with no set-aside designation and extends through September 30, 2026. As a specialized supplier of critical medical isotopes and radiopharmaceutical products,...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $56,525.22 for nuclear medicine radiopharmaceuticals by Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs. The contract, awarded on September 4, 2024, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price delivery order arrangement with no set-aside designation. Performance will be executed from...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $797,541.70 for the supply of various radiopharmaceuticals to the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9). The contract, executed on October 1, 2024, with an ultimate completion date of September 30, 2025, operates under a firm fixed-price structure with no set-aside designation. Cardinal Health 414, LLC will perform this work from its facility in Dublin,...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $372,703.55 for radiopharmaceutical supplies by Veterans Integrated Service Network 16 (VISN 16) on July 1, 2024. This firm fixed-price, unrestricted contract—with no set-aside designation—will be performed in Dublin, Ohio, and is scheduled for completion by June 30, 2025. Cardinal Health 414, LLC specializes in supplying critical medical isotopes and radiopharmaceutical products used in...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The contract has a potential value of $532,198.27 and a completion date of January 31, 2025. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. and is a major supplier of radiopharmaceuticals and specialized pharmaceutical products to...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a delivery order valued at $272,897.47 for radiopharmaceutical products to support the Huntington VA Medical Center. The contract, which is firm fixed price and carries no set-aside designation, runs through September 30, 2026, and was awarded on October 1, 2025. Cardinal Health 414, LLC will provide critical medical isotopes and radiopharmaceutical products from its Dublin, Ohio location, supporting nuclear...
- Cardinal Health 414, LLC will provide radiopharmaceuticals to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 under a firm fixed price delivery order worth $435,913.31. The one year contract runs from October 1, 2022 through September 30, 2023 to support nuclear medicine programs at the Dublin, Ohio VA medical center. Cardinal Health 414, a subsidiary of Cardinal Health, Inc., will deliver the requested radioactive isotopes, diagnostic...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $1.10M under the General Radiopharmaceutical Indefinite Delivery/Indefinite Quantity (IDIQ) contract on August 1, 2023. This decrease modification for General Radiopharmaceuticals FY23 represents a firm fixed-price contract with an ultimate completion date of July 31, 2024. The contract carries no set-aside designation and was awarded through unrestricted competition. Cardinal Health 414,...
- This is a delivery order for radiopharmaceuticals awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $422,984.61 firm fixed-price contract has an ultimate completion date of September 30, 2024 and was awarded on October 1, 2023. Cardinal Health 414 is a specialized provider of radiopharmaceuticals, radioactive isotopes, and related nuclear medicine products and services to federal healthcare agencies including the VA,...
- 36C25224D0011Indefinite Delivery Contract
- 36C25224D0011-36C25226N0134Delivery Order
Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at approximately $65K for radiopharmaceuticals by the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12). The contract, issued on November 1, 2025, with a completion date of October 31, 2026, operates under a firm fixed-price arrangement with no set-aside designation, indicating full and open competition. Cardinal Health 414, LLC will deliver specialized medical isotopes and radiopharmaceutical products from its Dublin, Ohio facility to support nuclear medicine and diagnostic imaging services across VA medical centers within the network. This delivery order is issued under one of Cardinal Health 414's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with VISN 12, part of the company's broader portfolio of radiopharmaceutical supply agreements with the VA system. Cardinal Health 414 specializes in providing time-sensitive, critical medical isotopes such as technetium-99m, iodine-123, and specialized radiopharmaceutical therapies to federal healthcare facilities. The company's established track record supplying radiopharmaceuticals to multiple VA networks and federal agencies demonstrates its capability to reliably deliver these essential products required for nuclear medicine procedures and cancer treatment applications at VA medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 10/27/25 |